Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Choline Fenofibrate on Carotid Atherosclerosis in T2DM Patients
NCT05365425Phase 4Recruiting
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jun 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fenofibric acid in atherosclerosis and dyslipidemia (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Carotid intima media thickness at 24 weeks. Started Jun 2023; status: recruiting.
02
Drugs
fenofibric acid
03
Conditions
atherosclerosisdyslipidemia
Beyond the preview
Go deeper on NCT05365425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05365425.